Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2.4 mg, an Italian real-world study.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2.4 mg, an Italian real-world study.
- Published In:
- Diabetes, obesity & metabolism (2026)
- Authors:
- Pampanelli, Simone, Terzoni, Stefano, Pantanetti, Paola, Di Loreto, Chiara, Mazzieri, Alessio, Cangelosi, Giovanni, Alberti, Sara, Badiali, Cristina, Grandone, Ilenia, Migliarelli, Sara, Castagna, Maria Grazia, Cerrai Ceroni, Mariaclaudia, Benenati, Nicoletta
- Database ID:
- RPEP-15854
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15854APA
Pampanelli, Simone; Terzoni, Stefano; Pantanetti, Paola; Di Loreto, Chiara; Mazzieri, Alessio; Cangelosi, Giovanni; Alberti, Sara; Badiali, Cristina; Grandone, Ilenia; Migliarelli, Sara; Castagna, Maria Grazia; Cerrai Ceroni, Mariaclaudia; Benenati, Nicoletta. (2026). Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2.4 mg, an Italian real-world study.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70538
MLA
Pampanelli, Simone, et al. "Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX-SEMA 2.4 mg, an Italian real-world study.." Diabetes, 2026. https://doi.org/10.1111/dom.70538
RethinkPeptides
RethinkPeptides Research Database. "Flexible dose of semaglutide reduces early discontinuation w..." RPEP-15854. Retrieved from https://rethinkpeptides.com/research/pampanelli-2026-flexible-dose-of-semaglutide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.